OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan
Ibrahim Mohammed, Morley D. Hollenberg, Hong Ding, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 194

Impaired fasting glucose and sulfonylureas increased the risk of major cardiovascular events in patients with inflammatory arthritis
Huan Meng, Ho So, Steven Ho Man Lam, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1

The Effectiveness of Metformin in Diabetes Prevention: A Systematic Review and Meta-Analysis
Dhara Patel, Ismat E Ayesha, N. Monson, et al.
Cureus (2023)
Open Access | Times Cited: 14

Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)
Jan Beneš, Martin Kotrč, Katerina Kroupova, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20

Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications
Isabella Bonilha, Francesca Zimetti, Ilaria Zanotti, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2233-2233
Open Access | Times Cited: 26

Repurposing Metformin for Vascular Disease
Chris R. Triggle, Isra Marei, Kevin Ye, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 35, pp. 3955-3978
Open Access | Times Cited: 17

Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
Vallo Volke, Urmeli Katus, Annika Johannson, et al.
BMC Endocrine Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 16

HIV Protease Inhibitors and Insulin Sensitivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Violet Dismas Kajogoo, Mary Gorret Atim, Demeke Amare, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 17

The Effect of Sodium-Glucose Co-Transporter 2 Inhibitors on Stroke and Atrial Fibrillation: A Systematic Review and Meta-Analysis
Kaneez Fatima, Azeema Suri, Aiman Rija, et al.
Current Problems in Cardiology (2022) Vol. 48, Iss. 4, pp. 101582-101582
Closed Access | Times Cited: 12

Association of Sodium-Glucose Cotransporter 2 Inhibitors with Osteomyelitis and Other Lower Limb Safety Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Alessandro Nani, Federica Carrara, Chiara Maria Eleonora Paulesu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 3958-3958
Open Access | Times Cited: 4

Ertugliflozin + metformin as a treatment option for type 2 diabetes
Vasilios G. Athyros, Chrysoula Boutari, Asterios Karagiannis
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 16, pp. 2105-2111
Closed Access | Times Cited: 4

Metformin in the management of patients with diabetes and advanced heart failure (HFrEF): a propensity score-matched analysis
Jan Beneš, Martin Kotrč, Katerina Kroupova, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1

Metformin in the management of patients with diabetes and advanced heart failure (HFrEF): a propensity score-matched analysis
Jan Beneš, Martin Kotrč, Katerina Kroupova, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top